ArticleFrontiers in oncology2021

GZ17-6.02 and Pemetrexed Interact to Kill Osimertinib-Resistant NSCLC Cells That Express Mutant ERBB1 Proteins.

Laurence Booth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.